Physician Assistant · San Leandro, CA
NPI
1497260772
Since 2017
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2500 Merced St
San Leandro, CA, 94577
Phone (510) 454-4813
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$215K
1,403 prescriptions
Company payments, 2023
$23.67
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Annie W Li prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 807 prescriptions and refills. In total Annie W Li wrote 1,403 Medicare prescriptions that cost $215K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 807 | 807 | 773 | $18K |
| Famotidine Generic | 58 | 179 | 37 | $760 |
| Cholestyramine Cholestyramine (With Sugar) | 49 | 50 | 23 | $2,082 |
| Omeprazole Generic | 46 | 63 | 25 | $532 |
| Lubiprostone Generic | 43 | 53 | 14 | $3,702 |
| Creon Lipase/Protease/Amylase | 35 | 106 | 16 | $48K |
| Pantoprazole Sodium Generic | 32 | 56 | 14 | $326 |
| Lactulose Generic | 30 | 30 | 18 | $830 |
| Xifaxan Rifaximin | 24 | 24 | 14 | $68K |
| Mesalamine Generic | 22 | 61 | 11 | $11K |
| Linzess Linaclotide | 20 | 33 | Under 11 | $20K |
| Ondansetron Odt Ondansetron | 19 | 19 | Under 11 | $149 |
| Cholestyramine Light Cholestyramine | 16 | 20 | Under 11 | $1,150 |
| Metoclopramide Hcl Generic | 16 | 16 | Under 11 | $676 |
| Motegrity Prucalopride Succinate | 15 | 15 | Under 11 | $8,762 |
Brand drugs: 161 claims; generic drugs: 1,242 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Annie W Li $23.67 ($23.67 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $23.67.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $23.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.